{
    "Trade/Device Name(s)": [
        "VITEK 2 Gram Negative Trimethoprim/sulfamethoxazole (\u2264 1/19 - \u2265 16/304 \u00b5g/ml)",
        "VITEK 2 AST-GN SXT"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K110106",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "November 10, 2011",
    "Summary Letter Received Date": "November 14, 2011",
    "Submission Date": "December 21, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Short-Term Antimicrobial Susceptibility Test System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trimethoprim/sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Gram-negative bacilli isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated susceptibility testing",
        "Miniaturized broth microdilution"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Broth microdilution"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Gram Negative Trimethoprim/sulfamethoxazole assay for automated antimicrobial susceptibility testing on VITEK 2 and VITEK 2 Compact systems",
    "Indications for Use Summary": "Qualitative test for in vitro susceptibility to trimethoprim/sulfamethoxazole of Gram-negative bacilli using VITEK 2 and VITEK 2 Compact systems as a laboratory aid.",
    "fda_folder": "Microbiology"
}